Reagents for IRICELL3000 for korea.

Ended Indefinite Delivery Contract Awarded Last action

Contract number
W81K0220D0009
Awardee
Awarding agency
Task orders
6 $288,475 obligated

Award facts

Opportunity
Combined order value
$288,475 Current and potential, with all options
Last date to order 100% complete
IDV ceiling 10% used
$2,937,284.04
Award type
Single award
Who can order
Only the awarding agency
Funding agency
Defense Health Agency Department of Defense
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Negotiated Proposal / Quote
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

About this IDV

This federal contract IDV award is a single-award Indefinite Delivery Contract (IDC) valued at $2,937,284.04, awarded by the Defense Health Agency (DHA) to the prime contractor BMI, a for-profit organization specializing in medical laboratory equipment and supplies. The IDC, awarded on July 1, 2020, is focused on providing reagents for the IRICell3000 system to support medical operations in South Korea through September 30, 2024. Under this IDC, the DHA and Army Medical Command have issued multiple firm fixed-price delivery orders to BMI, ranging from $28,000 to $91,000, for the delivery of reagents to locations in South Korea from October 2020 through September 2023. These reagents support ongoing medical testing, research, and health initiatives for U.S. military and civilian personnel in the region. The original solicitation for this requirement was a full and open competition, and the contract does not utilize any set-aside designations.

The scope of the contracted products and services includes the provision of reagents, consumables, and other supplies for the IRICell3000 hematology analyzer system used at military medical facilities in South Korea, primarily the Brian D. Allgood Army Hospital. The DHA, which manages the military health system and conducts medical research, has a need for a reliable supply of these critical laboratory reagents to support its global healthcare and medical operations missions.

Task orders

Transactions

Action Obligated Date
Exercise an Option P00008 · Reagents for IRICELL3000 MOD P00008 exercise option IV 10/01/2023-09/30/2024 $0
Supplemental Agreement for work within scope P00007 · Reagents for IRICELL3000 MOD P00007 to incorporate far 52.204-27 $0
Vendor Address Change P00006 · Reagents for IRICELL3000 MOD P00006: KTR address change $0
Other Administrative Action P00005 · Reagents for IRICELL3000 MOD P00005 clin restructuring $0
Exercise an Option P00004 · Reagents for IRICELL3000. Modification P00004: exercise option 3. $0
Exercise an Option P00003 · Requirement is for reagents for IRICELL3000 for korea. MOD is to exercise OPT II. $0
Supplemental Agreement for work within scope P00002 · 889 action - IRICELL3000 reagents for korea $0
Exercise an Option P00001 · Requirement is for reagents for IRICELL3000. MOD is to exercise OPT i. $0
Original award $0

Quick answers

Who was awarded contract W81K0220D0009?

W81K0220D0009 was awarded to BMI by Medical Command (Department of the Army) on July 1, 2020.

How much is contract W81K0220D0009 worth?

Orders under W81K0220D0009 have obligated $288,475. W81K0220D0009's own ceiling is $2,937,284.

How many orders have been placed under contract W81K0220D0009?

6 orders have been placed under W81K0220D0009, the latest on May 3, 2024.

Which agency awarded contract W81K0220D0009?

Medical Command (Department of the Army) awarded W81K0220D0009, with funding from Defense Health Agency (Department of Defense).

Who can order from contract W81K0220D0009?

W81K0220D0009 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.

Was contract W81K0220D0009 competed?

The extent of competition for W81K0220D0009 was full and open competition. The government received 1 offer.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV